Revive Therapeutics (OTC:RVVTF) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Revive Therapeutics (RVVTF) operate in?

Revive Therapeutics is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCQB.

Revive Therapeutics Stock (OTC: RVVTF) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 270.97K
Day Range	- - -
52 Wk Range	0.01 - 0.04
Market Cap	$2.51M
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	1

Recent News

EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves

Jamaica introduces its first legal psilocybin products in pharmacies through a historic partnership between PATOO and Fontana Pharmacy.

Javier Hasse

Psyched: Canada's Case For Psilocybin Access And Microdose Trial, US Reform Update, Battle With DEA & More

Canadian Patients Demand Access To Psilocybin: Federal Lawsuit, Official Petition & Failing Mechanism A patient-led lawsuit against the Canadian government is claiming access to therapeutic psilocybin is a constitutional right under the Canadian Charter of Rights and Freedoms.

Lara Goldstein

MDMA Transdermal Patch Moves Toward First-In-Human Trials: Latest Development Update

Specialty drug delivery technology biopharma company Revive Therapeutics Ltd. (OTCQB: RVVTF) is undertaking research and development activities for its proprietary transdermal microneedle patch to deliver MDMA toward IND-enabling studies, supported by an exclusive supply deal with PharmaAla Biotech Holdings Inc.

Lara Goldstein

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

About

Sector

Healthcare

Industry

N/A

Revive Therapeutics Ltd is focused on the research, development, and commercialization of novel psyc...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Revive Therapeutics (RVVTF) stock?

You can purchase shares of Revive Therapeutics (OTCQB:RVVTF) through any online brokerage.

View our list of the best stock brokerages

Who are Revive Therapeutics (RVVTF) competitors?

There are no as such competitors for Revive Therapeutics.

What is the forecast, or price target, for Revive Therapeutics (RVVTF) stock?

There is no analysis for Revive Therapeutics to provide a consensus price target.

What is the current price for Revive Therapeutics (RVVTF)?

The stock price for Revive Therapeutics (OTCQB: RVVTF) is $0.0245 last updated March 14, 2024 at 8:00 AM EDT.

Does Revive Therapeutics (RVVTF) pay a dividend?

There are no upcoming dividends for Revive Therapeutics.

When is Revive Therapeutics (OTCQB:RVVTF) reporting earnings?

Revive Therapeutics does not have any upcoming earnings scheduled.

Is Revive Therapeutics (RVVTF) going to split?

There is no upcoming split for Revive Therapeutics.

What sector and industry does Revive Therapeutics (RVVTF) operate in?

Revive Therapeutics is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCQB.

Get Our Top Trade Ideas Delivered Daily - 65% Off Now